<i>SERPINB9</i> is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade responseSofía Ibáñez-Molero, Daniel S. Peeper, Jean‐Christophe Marine et al.|OncoImmunology|2022Cited by 33